Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma

Chieh Wen Lai, Kuen Yuan Chen, Chin Sheng Hung, Shi Wen Kuo, Yao Jen Chang, Ming Tsan Lin, Kun Che Chang, Ming Hsun Wu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this multicenter study was to evaluate the clinical relevance of serum vascular endothelial growth factor-D (VEGF-D) in papillary thyroid carcinoma (PTC). This prospective study consisted of 74 patients with primary PTC and 15 patients with benign thyroid nodules treated from 2008 to 2009. VEGF-D concentration was compared with patient clinicopathologic features and lymph node metastases. There was no significant difference in mean serum VEGF-D levels between the PTC and benign thyroid nodule groups. Within the PTC group, serum VEGF-D levels were significantly higher in patients with lymph node metastases than in patients without metastases (241.92 vs. 213.89 pg/ml, respectively; P = 0.035). Receiver operating characteristic curve analysis revealed that preoperative serum VEGF-D levels were predictive of lymph node metastases in the patients >45 years. Serum VEGF-D level that was correlated with the presence of cervical lymph node metastases in PTC patients might be a useful prognostic indicator.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalGrowth Factors
Volume29
Issue number2-3
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Vascular Endothelial Growth Factor D
Lymph Nodes
Neoplasm Metastasis
Serum
Thyroid Nodule
Papillary Thyroid cancer
ROC Curve
Multicenter Studies
Prospective Studies

Keywords

  • lymph node
  • metastasis
  • Papillary thyroid cancer
  • serum marker
  • VEGF-D

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma. / Lai, Chieh Wen; Chen, Kuen Yuan; Hung, Chin Sheng; Kuo, Shi Wen; Chang, Yao Jen; Lin, Ming Tsan; Chang, Kun Che; Wu, Ming Hsun.

In: Growth Factors, Vol. 29, No. 2-3, 04.2011, p. 57-62.

Research output: Contribution to journalArticle

Lai, Chieh Wen ; Chen, Kuen Yuan ; Hung, Chin Sheng ; Kuo, Shi Wen ; Chang, Yao Jen ; Lin, Ming Tsan ; Chang, Kun Che ; Wu, Ming Hsun. / Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma. In: Growth Factors. 2011 ; Vol. 29, No. 2-3. pp. 57-62.
@article{95bce1e0806e4899b48936ddebf25573,
title = "Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma",
abstract = "The aim of this multicenter study was to evaluate the clinical relevance of serum vascular endothelial growth factor-D (VEGF-D) in papillary thyroid carcinoma (PTC). This prospective study consisted of 74 patients with primary PTC and 15 patients with benign thyroid nodules treated from 2008 to 2009. VEGF-D concentration was compared with patient clinicopathologic features and lymph node metastases. There was no significant difference in mean serum VEGF-D levels between the PTC and benign thyroid nodule groups. Within the PTC group, serum VEGF-D levels were significantly higher in patients with lymph node metastases than in patients without metastases (241.92 vs. 213.89 pg/ml, respectively; P = 0.035). Receiver operating characteristic curve analysis revealed that preoperative serum VEGF-D levels were predictive of lymph node metastases in the patients >45 years. Serum VEGF-D level that was correlated with the presence of cervical lymph node metastases in PTC patients might be a useful prognostic indicator.",
keywords = "lymph node, metastasis, Papillary thyroid cancer, serum marker, VEGF-D",
author = "Lai, {Chieh Wen} and Chen, {Kuen Yuan} and Hung, {Chin Sheng} and Kuo, {Shi Wen} and Chang, {Yao Jen} and Lin, {Ming Tsan} and Chang, {Kun Che} and Wu, {Ming Hsun}",
year = "2011",
month = "4",
doi = "10.3109/08977194.2011.557373",
language = "English",
volume = "29",
pages = "57--62",
journal = "Growth Factors",
issn = "0897-7194",
publisher = "Informa Healthcare",
number = "2-3",

}

TY - JOUR

T1 - Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma

AU - Lai, Chieh Wen

AU - Chen, Kuen Yuan

AU - Hung, Chin Sheng

AU - Kuo, Shi Wen

AU - Chang, Yao Jen

AU - Lin, Ming Tsan

AU - Chang, Kun Che

AU - Wu, Ming Hsun

PY - 2011/4

Y1 - 2011/4

N2 - The aim of this multicenter study was to evaluate the clinical relevance of serum vascular endothelial growth factor-D (VEGF-D) in papillary thyroid carcinoma (PTC). This prospective study consisted of 74 patients with primary PTC and 15 patients with benign thyroid nodules treated from 2008 to 2009. VEGF-D concentration was compared with patient clinicopathologic features and lymph node metastases. There was no significant difference in mean serum VEGF-D levels between the PTC and benign thyroid nodule groups. Within the PTC group, serum VEGF-D levels were significantly higher in patients with lymph node metastases than in patients without metastases (241.92 vs. 213.89 pg/ml, respectively; P = 0.035). Receiver operating characteristic curve analysis revealed that preoperative serum VEGF-D levels were predictive of lymph node metastases in the patients >45 years. Serum VEGF-D level that was correlated with the presence of cervical lymph node metastases in PTC patients might be a useful prognostic indicator.

AB - The aim of this multicenter study was to evaluate the clinical relevance of serum vascular endothelial growth factor-D (VEGF-D) in papillary thyroid carcinoma (PTC). This prospective study consisted of 74 patients with primary PTC and 15 patients with benign thyroid nodules treated from 2008 to 2009. VEGF-D concentration was compared with patient clinicopathologic features and lymph node metastases. There was no significant difference in mean serum VEGF-D levels between the PTC and benign thyroid nodule groups. Within the PTC group, serum VEGF-D levels were significantly higher in patients with lymph node metastases than in patients without metastases (241.92 vs. 213.89 pg/ml, respectively; P = 0.035). Receiver operating characteristic curve analysis revealed that preoperative serum VEGF-D levels were predictive of lymph node metastases in the patients >45 years. Serum VEGF-D level that was correlated with the presence of cervical lymph node metastases in PTC patients might be a useful prognostic indicator.

KW - lymph node

KW - metastasis

KW - Papillary thyroid cancer

KW - serum marker

KW - VEGF-D

UR - http://www.scopus.com/inward/record.url?scp=79955846725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955846725&partnerID=8YFLogxK

U2 - 10.3109/08977194.2011.557373

DO - 10.3109/08977194.2011.557373

M3 - Article

C2 - 21319951

AN - SCOPUS:79955846725

VL - 29

SP - 57

EP - 62

JO - Growth Factors

JF - Growth Factors

SN - 0897-7194

IS - 2-3

ER -